Cargando…
Behavioural Phenotyping of APP(swe)/PS1(δE9) Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment
Alzheimer’s disease (AD) is a devastating illness characterized by a progressive loss of cognitive, social, and emotional functions, including memory impairments and more global cognitive deficits. Clinical-epidemiological evidence suggests that neuropsychiatric symptoms precede the onset of cogniti...
Autores principales: | Olesen, Louise Ørum, Bouzinova, Elena V., Severino, Maurizio, Sivasaravanaparan, Mithula, Hasselstrøm, Jørgen Bo, Finsen, Bente, Wiborg, Ove |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096719/ https://www.ncbi.nlm.nih.gov/pubmed/27814403 http://dx.doi.org/10.1371/journal.pone.0165144 |
Ejemplares similares
-
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
por: Severino, Maurizio, et al.
Publicado: (2018) -
Microglia Express Insulin-Like Growth Factor-1 in the Hippocampus of Aged APP(swe)/PS1(ΔE9) Transgenic Mice
por: Myhre, Christa Løth, et al.
Publicado: (2019) -
Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APP(SWE)/PS1(ΔE9) Transgenic Mice Implicate Cathepsin Z in Alzheimer’s Disease
por: Thygesen, Camilla, et al.
Publicado: (2018) -
The Lack of Amyloidogenic Activity Is Persistent in Old WT and APP(swe)/PS1ΔE9 Mouse Retinae
por: Joly, Sandrine, et al.
Publicado: (2021) -
Longitudinal investigation of neuroinflammation and metabolite profiles in the APP
(swe)×PS1(Δe9) transgenic mouse model of Alzheimer's disease
por: Chaney, Aisling, et al.
Publicado: (2017)